Enexis

Investment and strategic direction are led by Co-founder and CEO David Bonnier and Co-founder Amaury de Poret. Bonnier brings over 20 years of investment management and banking experience from Brummer & Partners and Deutsche Bank, while de Poret contributes equivalent experience in private equity legal advisory and investment management. The board, chaired by former US cannabis CEO Per Björkman, provides additional sector-specific governance.

David Bonnier, the firm's Co-founder and CEO, is a member of the prominent Swedish Bonnier family, which controls the Bonnier Group, a privately held media conglomerate spanning books, newspapers, and broadcasting. Enexis operates as a separate investment company and does not manage the Bonnier family's wider assets, though the family connection provides institutional credibility within the Swedish investment landscape.

Enexis positions itself as an investment company focused on long-term capital appreciation, not fee generation. The firm states it has invested a substantial amount of operating capital and is incentivized solely by investment returns, a structure that more closely resembles a permanent-capital holding company than a traditional venture capital fund with a defined fund life and management fee schedule.

The firm's public materials do not explicitly state a policy on co-investments with external limited partners. However, Enexis emphasizes it wants portfolio company founders to run their businesses without pressure for a fast exit, implying a concentrated, patient-capital approach that typically favors proprietary or lead-investor positions rather than broad syndication.

Enexis reports building over three years an extensive network and deep understanding of the European cannabis and plant-based industry's complex regulatory nuances. The firm's nexus within the Alma private business club in Stockholm and relationships with established investors like Sebastian Siemiatkowski provide informal channels into early-stage deal flow across the region.

There is no public disclosure of separate philanthropic structures operated by Enexis. Board member Amaury de Poret has affiliations with listed investment companies NAXS AB and Flat Capital AB, and CEO David Bonnier chairs NORDx Pharma AB and sits on the board of Amidea Sweden AB, indicating a network of related but discrete for-profit investment entities.